SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as the European Commission's authorization of ANKTIVA for bladder cancer across 33 countries fuels fervent community discussion about a potential short squeeze due to high short interest and the drug's revolutionary impact on cancer treatment.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently trending ahead of its highly anticipated earnings report, driving a significant debate among the community. Investors are sharply divided between those expecting continued growth driven by its defensive consumer staples position and e-commerce initiatives, and those expressing strong concerns about its elevated valuation relative to historical norms and industry peers.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending ahead of its earnings report, with community discussion polarized between strong bullish sentiment fueled by recent insider buying and analyst upgrades, and bearish concerns over its high valuation, intense competition, consumer spending pressures, and challenges with driver compensation and regulatory oversight.

WorldFinancial

WorldFinancial (WLFI) is a focal point of discussion as its Mar-a-Lago forum, featuring prominent financial leaders, drives anticipation for potential institutional adoption and further integration of its USD1 stablecoin. This bullish sentiment is countered by ongoing U.S. House investigations into the Trump-linked crypto project's foreign investments and alleged conflicts of interest, fueling a polarized community debate.

QuickLogic Corp. operates as a semiconductor company, which designs, markets, and supports primarily Customer Specific Standard Products and secondarily, Field Programmable Gate Arrays, sensor software algorithms, software drivers, associated design software and programming hardware. It develops and markets low power customizable semiconductor and software algorithm solutions that enable customers to differentiate their products by adding new features, extending battery life, becoming more contextually aware and improving the visual experience with their mobile, consumer and enterprise products. The company was founded by John M. Birkner, Andrew K. Chan, and Hua-Thye Chua in 1988 and is headquartered in San Jose, CA.

Quicklogic Corp

Substantial defense contract awards for its Strategic Radiation Hardened program, alongside strategic advancements in chiplet technology including the PACE ecosystem and collaboration with Intel's 18A process, are propelling QuickLogic's market conversation. While the community is optimistic about these catalysts driving significant revenue growth in 2026 and potential Russell 2000 re-entry, some caution remains due to past execution delays and notable short interest.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing strong discussion after beating Q2 revenue and ARR estimates and raising its full-year revenue outlook, yet the stock is down due to a lowered EPS guidance attributed to acquisition and integration costs. The community is debating whether this reflects a healthy long-term investment in AI-driven cybersecurity expansion or a concern over near-term margin pressure in the software sector.

Tidal Trust II - YieldMax MSTR Short Option Income Strategy ETF

YieldMax MSTR Short Option Income Strategy ETF

YieldMax MSTR Short Option Income Strategy ETF (WNTR) is trending after experiencing a trading halt due to increased volatility, sparking active community discussion around its weekly dividend payouts and its role as an effective inverse hedge against MSTY amidst MicroStrategy's recent performance.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending due to significant upward momentum and widespread community speculation about an impending short squeeze, fueled by its extremely low float and high short interest. This is set against the broader backdrop of the highly anticipated Space X IPO, which is prompting intense debate among traders regarding FJET's potential for explosive gains within the space sector, despite some skepticism over its business fundamentals.

American Superconductor Corp. engages in the provision of megawatt-scale power solutions. Its products include electric control systems, generators & drivetrains, power converters, renewable interconnectivity solutions, software, turbine designs, utility and industrial resilience and modernization solutions, and utility voltage solutions. It operates through the Grid and Wind segments. The Grid segment enables electric utilities and renewable energy project developers to connect, transmit, and distribute power with efficiency, reliability, security, and affordability. The Wind segment permits the manufacturers to field wind turbines with power output, reliability, and affordability. The company was founded by Yet Ming Chiang, David A. Rudman, John B. Vander Sande, and Gregory J. Yurek on April 9, 1987 and is headquartered in Ayer, MA.

American Superconductor Corp.

American Superconductor is a major topic after reporting robust financial results and strong guidance, sparking community optimism about its essential role in grid modernization and AI data center power infrastructure; however, a recent stock offering and subsequent price volatility have led to active investor debate.

Remitly Global, Inc. engages in the provision of digital financial services for immigrants and their families. The company was founded by Matthew B. Oppenheimer and Joshua Hug on October 3, 2018 and is headquartered in Seattle, WA.

Remitly Global Inc

Investors are actively discussing Remitly Global (RELY) ahead of its earnings report, with many expecting a significant post-release rally fueled by its strong digital money transfer growth and AI initiatives. However, some remain cautious, recalling a historical pattern of price drops despite positive past results, leading to a divided community sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MGTX zipbio

To clarify, MeiraGTx (MGTX) did not purchase the entire company ZipBio; rather, they executed an exclusive licensing agreement in February 2026. This deal grants MeiraGTx the rights to specific assets from ZipBio.
Here is a summary of the benefits of this transaction for MeiraGTx:
1. Pipeline Expansion into a High-Value Indication
• The Asset: MeiraGTx gains exclusive rights to ZipBio’s &quot;first-in-class&quot; Geographic Atrophy (GA) gene therapy program.
• The Market: Geographic Atrophy is a late-stage form of Age-Related Macular Degeneration (AMD) that leads to permanent vision loss. It represents a massive unmet medical need with limited effective treatments, offering significant revenue potential if successful.

Mike Long

StockTwits for iOS

MeiraGTx Holdings plc

 zipbio

To clarify, MeiraGTx (MGTX) did not purchase the entire company ZipBio; rather, they executed an exclusive licensing agreement in February 2026. This deal grants MeiraGTx the rights to specific assets from ZipBio.
Here is a summary of the benefits of this transaction for MeiraGTx:
1. Pipeline Expansion into a High-Value Indication
• The Asset: MeiraGTx gains exclusive rights to ZipBio’s "first-in-class" Geographic Atrophy (GA) gene therapy program.
• The Market: Geographic Atrophy is a late-stage form of Age-Related Macular Degeneration (AMD) that leads to permanent vision loss. It represents a massive unmet medical need with limited effective treatments, offering significant revenue potential if successful.

ETFis Series Trust I - Virtus InfraCap U.S. Preferred Stock ETF

iShares Bitcoin ETF

NEOS Bitcoin High Income ETF

Meira

2. Access to Advanced AI Technology
• The Tech: The deal gives MeiraGTx access to proteins designed using ZipBio’s proprietary COMPACT™ generative AI platform.
• The Benefit: This AI technology designs &quot;Zip® drugs&quot;—compact, multifunctional proteins that can fit inside standard gene therapy delivery vehicles (like AAV vectors) more easily than traditional, larger proteins. This solves a major engineering bottleneck in gene therapy.
3. Strategic Synergies
• Best-of-Both-Worlds: The deal pairs ZipBio’s AI-designed payloads (the therapeutic protein) with MeiraGTx’s established AAV vector manufacturing and clinical development capabilities.
• Vertical Integration: MeiraGTx can now use its in-house manufacturing facilities to produce these novel, AI-designed therapies, potentially speeding up development and reducing costs.

2. Access to Advanced AI Technology
• The Tech: The deal gives MeiraGTx access to proteins designed using ZipBio’s proprietary COMPACT™ generative AI platform.
• The Benefit: This AI technology designs "Zip® drugs"—compact, multifunctional proteins that can fit inside standard gene therapy delivery vehicles (like AAV vectors) more easily than traditional, larger proteins. This solves a major engineering bottleneck in gene therapy.
3. Strategic Synergies
• Best-of-Both-Worlds: The deal pairs ZipBio’s AI-designed payloads (the therapeutic protein) with MeiraGTx’s established AAV vector manufacturing and clinical development capabilities.
• Vertical Integration: MeiraGTx can now use its in-house manufacturing facilities to produce these novel, AI-designed therapies, potentially speeding up development and reducing costs.

4. Strengthening the Ophthalmology Franchise
• This deal reinforces MeiraGTx&#39;s focus on eye diseases. It sits alongside their other major recent wins, such as their $475 million collaboration with Eli Lilly (which included a $75 million upfront payment to MeiraGTx) for other ocular gene therapies. The ZipBio asset adds another &quot;shot on goal&quot; in the eye care space without requiring MeiraGTx to build the drug discovery engine from scratch.
Summary: The primary benefit is that MeiraGTx effectively &quot;outsourced&quot; the discovery of a cutting-edge GA drug to ZipBio&#39;s AI, allowing MeiraGTx to focus on what it does best: clinical development and manufacturing.

4. Strengthening the Ophthalmology Franchise
• This deal reinforces MeiraGTx's focus on eye diseases. It sits alongside their other major recent wins, such as their $475 million collaboration with Eli Lilly (which included a $75 million upfront payment to MeiraGTx) for other ocular gene therapies. The ZipBio asset adds another "shot on goal" in the eye care space without requiring MeiraGTx to build the drug discovery engine from scratch.
Summary: The primary benefit is that MeiraGTx effectively "outsourced" the discovery of a cutting-edge GA drug to ZipBio's AI, allowing MeiraGTx to focus on what it does best: clinical development and manufacturing.